Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry

Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry

Background and Objective: Oral anticoagulation (OAC) for secondary stroke prevention is recommended in atrial fibrillation (AF) and other sources of cardioembolic stroke. Our objectives were to explore the differences in ischemic and hemorrhagic events when using OAC for secondary stroke prevention...

Full description

Bibliographic Details
Main Authors: Raquel Gutiérrez-Zúñiga, Ricardo Rigual, Gabriel Torres-Iglesias, Sara Sánchez-Velasco, María Alonso de Leciñana, Jaime Masjuan, Rodrigo Álvarez Velasco, Inmaculada Navas, Laura Izquierdo-Esteban, José Fernández-Ferro, Jorge Rodríguez-Pardo, Gerardo Ruiz-Ares, Gustavo Zapata-Wainberg, Blanca Fuentes, Exuperio Díez-Tejedor
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Neurology
Subjects:
secondary stroke prevention
anticoagulant drugs
stroke recurrence
hemorrhage risk
multicenter registry
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.575634/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.575634/full

Similar Items